TY  - GEN
AU  - Ammoun,Sylwia
AU  - Evans,D Gareth
AU  - Hilton,David A
AU  - Streeter,Adam
AU  - Hayward,Christopher
AU  - Hanemann,C Oliver
TI  - Phase 0 trial investigating the intratumoural concentration and activity of sorafenib in neurofibromatosis type 2
SN  - 1468-330X
PY  - 2020///0618
KW  - Adult
KW  - Antineoplastic Agents
KW  - metabolism
KW  - Blotting, Western
KW  - Caspase 3
KW  - drug effects
KW  - Cyclin D1
KW  - Humans
KW  - Immunohistochemistry
KW  - Leukocytes, Mononuclear
KW  - Mitogen-Activated Protein Kinase 1
KW  - Mitogen-Activated Protein Kinase 3
KW  - Molecular Targeted Therapy
KW  - Neurofibromatosis 2
KW  - drug therapy
KW  - Proto-Oncogene Proteins c-akt
KW  - Receptor, Platelet-Derived Growth Factor beta
KW  - Ribosomal Protein S6
KW  - Sorafenib
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/jnnp-2018-319713
ER  -